Cargando…
GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
Estrogenic hormone replacement therapy increases the risk of developing ovarian cancer, and estrogen promotes tumour initiation and growth in mouse models of this disease. GREB1 (Growth regulation by estrogen in breast cancer 1) is an ESR1 (estrogen receptor 1)-upregulated protein which may mediate...
Autores principales: | Hodgkinson, Kendra, Forrest, Laura A., Vuong, Nhung, Garson, Kenneth, Djordjevic, Bojana, Vanderhyden, Barbara C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212416/ https://www.ncbi.nlm.nih.gov/pubmed/29973689 http://dx.doi.org/10.1038/s41388-018-0377-y |
Ejemplares similares
-
17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo
por: Laviolette, Laura A, et al.
Publicado: (2014) -
Single-cell RNA-sequencing reveals transcriptional dynamics of estrogen-induced dysplasia in the ovarian surface epithelium
por: Vuong, Nhung H., et al.
Publicado: (2018) -
17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression
por: Vuong, Nhung H., et al.
Publicado: (2017) -
Technical challenges and limitations of current mouse models of ovarian cancer
por: Garson, Kenneth, et al.
Publicado: (2012) -
Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers
por: Cheng, Meng, et al.
Publicado: (2018)